Thomas G. Cotter - Publications

Neighborhood Disadvantage and Access to Liver Transplant Referral for Severe Alcohol-Associated Hepatitis.

Journal: JAMA network open

Published: March 19, 2026

Reply: Interpreting outcomes in early liver transplantation.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 13, 2026

Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD.

Journal: Hepatology communications

Published: February 25, 2026

Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining.

Journal: Hepatology communications

Published: January 30, 2026

Impact of Documented Social Vulnerability on Clinical Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 03, 2026

Inequality in Pediatric Liver Transplantation.

Journal: Pediatrics

Published: December 10, 2025

Prognostic biomarkers in Fontan associated liver disease.

Journal: Translational pediatrics

Published: November 29, 2025

Assessment of early return to drinking in surviving patients with alcohol-associated hepatitis.

Journal: Alcohol, clinical & experimental research

Published: October 28, 2025

Racial Disparities in Pediatric Patients With Cholestatic Liver Disease Undergoing Liver Transplant: A UNOS Database Study.

Journal: Pediatric transplantation

Published: October 17, 2025

Integrating Phosphatidylethanol to Enhance Alcohol Quantification in Steatotic Liver Disease and Clinical Trials.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 27, 2025

Serum predictors of native liver survival post-Kasai: Systematic review and meta-analysis.

Journal: Journal of pediatric gastroenterology and nutrition

Published: June 25, 2025

Pharmacotherapy for Alcohol Use Disorder Is Underutilized Among Commercially Insured Adults With Alcohol-Associated Liver Disease.

Journal: Gastro hep advances

Published: June 10, 2025